Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Mathurin

Showing results (151-160 of 286) with videos related to

Pageof 29
Sort By:
Gut|February 15, 2007
micro-Opioid receptor activation prevents acute hepatic inflammation and cell deathDania Chakass, David Philippe, Edmone Erdual, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2023
Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case-control studyMassih Ningarhari, Marlène Bertez, Anne Ploquin, et al.
Plos One|March 21, 2012
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataThierry Poynard, Guillaume Lassailly, Emmanuel Diaz, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 28, 2022
Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver TransplantationKate Minoux, Guillaume Lassailly, Massih Ningarhari, et al.
Journal of Hepatology|February 15, 2003
A comparison of fibrosis progression in chronic liver diseasesThierry Poynard, Philippe Mathurin, Ching-Lung Lai, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approachAbbas Mourad, Sylvie Deuffic-Burban, Nathalie Ganne-Carrié, et al.
Cardiovascular and Interventional Radiology|October 25, 2014
Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation StudyXavier Pauwels, Mustapha Azahaf, Guillaume Lassailly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival: A National AnalysisLucia Parlati, Charlotte Mouliade, Eric Nguyen Khac, et al.
Gastro Hep Advances|August 12, 2024
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis BThierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
Journal of Hepatology|December 15, 2010
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitisVlad Ratziu, Victor de Ledinghen, Fréderic Oberti, et al.
Pageof 29

Showing results (151-160 of 286) with videos related to

Sort By:
Pageof 29
Gut|February 15, 2007
micro-Opioid receptor activation prevents acute hepatic inflammation and cell deathDania Chakass, David Philippe, Edmone Erdual, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 30, 2023
Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case-control studyMassih Ningarhari, Marlène Bertez, Anne Ploquin, et al.
Plos One|March 21, 2012
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataThierry Poynard, Guillaume Lassailly, Emmanuel Diaz, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 28, 2022
Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver TransplantationKate Minoux, Guillaume Lassailly, Massih Ningarhari, et al.
Journal of Hepatology|February 15, 2003
A comparison of fibrosis progression in chronic liver diseasesThierry Poynard, Philippe Mathurin, Ching-Lung Lai, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approachAbbas Mourad, Sylvie Deuffic-Burban, Nathalie Ganne-Carrié, et al.
Cardiovascular and Interventional Radiology|October 25, 2014
Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation StudyXavier Pauwels, Mustapha Azahaf, Guillaume Lassailly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival: A National AnalysisLucia Parlati, Charlotte Mouliade, Eric Nguyen Khac, et al.
Gastro Hep Advances|August 12, 2024
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis BThierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
Journal of Hepatology|December 15, 2010
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitisVlad Ratziu, Victor de Ledinghen, Fréderic Oberti, et al.
Pageof 29